U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812052) titled 'Short Course Radiation Treatment for Patients with Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery' on Jan. 27.
Brief Summary: To determine the safety of moderately hypofractionated radiation in the treatment of primary and locally recurrent RPS, based on the evaluation of acute radiation-related toxicity profile of each participant (30-day radiation toxicity)
Study Start Date: Feb., 2025
Study Type: OBSERVATIONAL
Condition:
Retroperitoneal Sarcoma
Intervention:
RADIATION: Radiation Therapy
In this study, patients will receive a hypofractionated course of radiation therapy of 2.85 Gy x 15 fractions (42.75...